ClinicalTrials.gov
ClinicalTrials.gov Menu

The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01566695
Recruitment Status : Active, not recruiting
First Posted : March 29, 2012
Last Update Posted : May 24, 2018
Sponsor:
Information provided by (Responsible Party):
Celgene